Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125851633 | 12585163 | 3 | F | 20160325 | 20160725 | 20160723 | 20160803 | EXP | 360430 | IT-ACCORD-041160 | ACCORD | 68.00 | YR | M | Y | 83.00000 | KG | 20160803 | MD | IT | IT |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125851633 | 12585163 | 1 | PS | CAPECITABINE ACCORD | CAPECITABINE | 1 | Oral | THE PATIENT UNDERWENT THE FIRST CYCLE XELOX | 202593 | 3000 | MG | TABLET | |||||||
| 125851633 | 12585163 | 2 | SS | SIMVASTATIN. | SIMVASTATIN | 1 | U | 78155 | |||||||||||
| 125851633 | 12585163 | 3 | SS | OXALIPLATIN. | OXALIPLATIN | 1 | Intravenous (not otherwise specified) | THE PATIENT UNDERWENT THE FIRST CYCLE XELOX | 200750096 | 160 | MG | SOLUTION FOR INFUSION | |||||||
| 125851633 | 12585163 | 4 | C | MOVICOL | POLYETHYLENE GLYCOL 3350POTASSIUM CHLORIDESODIUM BICARBONATESODIUM CHLORIDE | 1 | STRENGTH: 13.8 MG | 0 | POWDER FOR ORAL SOLUTION | ||||||||||
| 125851633 | 12585163 | 5 | C | LOSARTAN/LOSARTAN POTASSIUM | 2 | 0 | |||||||||||||
| 125851633 | 12585163 | 6 | C | DUTASTERIDE. | DUTASTERIDE | 1 | 0 | ||||||||||||
| 125851633 | 12585163 | 7 | C | ALFUZOSIN/ALFUZOSIN HYDROCHLORIDE | 2 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125851633 | 12585163 | 1 | Adenocarcinoma of colon |
| 125851633 | 12585163 | 2 | Hypercholesterolaemia |
| 125851633 | 12585163 | 3 | Adenocarcinoma of colon |
| 125851633 | 12585163 | 5 | Essential hypertension |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125851633 | 12585163 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125851633 | 12585163 | Actinic keratosis | |
| 125851633 | 12585163 | Constipation | |
| 125851633 | 12585163 | Thrombocytopenia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125851633 | 12585163 | 1 | 20160321 | 0 | ||
| 125851633 | 12585163 | 3 | 20160321 | 0 |